65,33 €
72,59 €
-10% with code: EXTRA
B Cell Immunotherapy in Oral Cancer
B Cell Immunotherapy in Oral Cancer
65,33
72,59 €
  • We will send in 10–14 business days.
As the emerging trend in therapeutics of cancer refocus on immunotherapy, it is one of the most effective measure to reduce the current rate of mortality and morbidity rate. Immunotherapy has been still at a progressive note for complete recovery of tumor and its recurrence. T cell based immunotherapy has been recognised for its role in curbing the tumor progression rate. Although, the role of B cells is still at controversy. Exploring both the antitumorogenic and protumorogenic responses in a…
  • Publisher:
  • ISBN-10: 1952751438
  • ISBN-13: 9781952751431
  • Format: 15.2 x 22.9 x 0.4 cm, softcover
  • Language: English
  • SAVE -10% with code: EXTRA

B Cell Immunotherapy in Oral Cancer (e-book) (used book) | bookbook.eu

Reviews

(4.00 Goodreads rating)

Description

As the emerging trend in therapeutics of cancer refocus on immunotherapy, it is one of the most effective measure to reduce the current rate of mortality and morbidity rate. Immunotherapy has been still at a progressive note for complete recovery of tumor and its recurrence. T cell based immunotherapy has been recognised for its role in curbing the tumor progression rate. Although, the role of B cells is still at controversy. Exploring both the antitumorogenic and protumorogenic responses in a tumor microenvironment emphasis this fact to reconsider the role of B lymphocyte.

EXTRA 10 % discount with code: EXTRA

65,33
72,59 €
We will send in 10–14 business days.

The promotion ends in 19d.09:56:12

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 0,73 Book Euros!?
  • Author: Anela Thomas
  • Publisher:
  • ISBN-10: 1952751438
  • ISBN-13: 9781952751431
  • Format: 15.2 x 22.9 x 0.4 cm, softcover
  • Language: English English

As the emerging trend in therapeutics of cancer refocus on immunotherapy, it is one of the most effective measure to reduce the current rate of mortality and morbidity rate. Immunotherapy has been still at a progressive note for complete recovery of tumor and its recurrence. T cell based immunotherapy has been recognised for its role in curbing the tumor progression rate. Although, the role of B cells is still at controversy. Exploring both the antitumorogenic and protumorogenic responses in a tumor microenvironment emphasis this fact to reconsider the role of B lymphocyte.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)